Learn how cell-free DNA is used for disease biomarker detection
Infographic

Cell-Free DNA in Clinical Diagnostics

Advancements in measuring DNA in bodily fluids create new opportunities for understanding disease.

Share

Cell-free DNA (cfDNA) is a noninvasive and informative disease biomarker, providing relevant information regarding disease characteristics and origins. Its use in clinical diagnostics was previously limited, but recent improvements in automation and high-throughput screening machinery allow scientists to classify cfDNA rapidly in large patient populations.

Download this poster from Tecan to discover how technological innovation enables faster cfDNA-mediated diagnosis.

Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio